Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its ...

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

Proponents of Ozempic microdosing claim you'll reap the drug's benefits with fewer side effects. But is taking small doses of GLP-1 agonists safe and effective for weight loss?

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...

Big Pharma is hiding a massive secret about so-called miracle weight-loss drugs like Ozempic – they come with a raft of ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Personalized Health Rx™ (PHRx), a new direct-to-consumer telehealth platform under the parent brand Persona 3.0 and sister company to Persona™ Nutrition, opened its digital doors today with a mission ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity. Individuals with overweight are at an ...

"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...

Discover the top stocks for the new year selected by Needham analysts, including ACV Auctions, Alcon, Alegro Microsystems, ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following ...